Emerging studies link dysregulated m6A machinery to diverse kidney diseases, including acute/chronic kidney injury (WTAP/METTL3/FTO in oxidative stress and fibrosis), and diabetic nephropathy (METTL14/FTO polymorphisms in susceptibility). This evidence concerns the gene FTO and kidney disorder.